What is the maximum daily dose of citalopram?

Maximum Daily Dose of Citalopram

The maximum daily dose of citalopram is 40 mg/day for most adults, with a reduced maximum of 20 mg/day for patients over 60 years of age, those with hepatic impairment, CYP2C19 poor metabolizers, or patients taking CYP2C19 inhibitors (such as cimetidine). 1

Standard Dosing Guidelines

The FDA-approved labeling establishes clear maximum dose limits based on the risk of QT interval prolongation, which can lead to Torsade de Pointes, ventricular tachycardia, and sudden death 1. These limits are:

• General adult population (≤60 years): Maximum 40 mg/day
• Patients >60 years: Maximum 20 mg/day
• Hepatic impairment: Maximum 20 mg/day
• CYP2C19 poor metabolizers: Maximum 20 mg/day
• Concurrent CYP2C19 inhibitors: Maximum 20 mg/day

The initial dose should be 20 mg once daily, with increases to 40 mg/day only after at least one week if needed 1. Doses above 40 mg/day are explicitly not recommended 1.

Critical Safety Considerations

QT prolongation risk is the primary concern driving these dose restrictions. Multiple guidelines confirm that citalopram causes dose-dependent QT prolongation associated with serious cardiac arrhythmias at daily doses exceeding 40 mg/day 2. This risk is particularly pronounced in:

• Elderly patients (>60 years), who show 23-30% increased drug exposure 1
• Patients with long QT syndrome (citalopram should be avoided entirely) 2
• Those taking other QT-prolonging medications 2

The 2020 AACAP guidelines specifically warn that citalopram "may cause QT prolongation associated with Torsade de Pointes, ventricular tachycardia, and sudden death at daily doses exceeding 40 mg/d" 2.

Historical Context and Clinical Reality

Prior to 2011 FDA guidance, citalopram was commonly prescribed at doses up to 60 mg/day 3. Research from 2002 showed that 40-60 mg/day doses demonstrated superior efficacy compared to lower doses 3. However, following the FDA safety communication, maximum doses were restricted due to cardiac safety concerns 4.

A critical caveat: One large Veterans Health Administration study found that reducing citalopram doses from >40 mg/day to ≤40 mg/day was associated with increased hospitalizations (adjusted hazard ratio 4.5) and hospitalizations for depression (adjusted hazard ratio 2.2), without reducing mortality or cardiac arrhythmia hospitalizations 5. This suggests the dose restrictions may have unintended clinical consequences in patients previously stabilized on higher doses.

Practical Prescribing Algorithm

For new patients:

1. Start 20 mg/day once daily (morning or evening, with or without food)
2. If inadequate response after ≥1 week, increase to 40 mg/day (if age ≤60 and no other risk factors)
3. Never exceed 40 mg/day in general population or 20 mg/day in high-risk groups

For elderly patients (>60 years):

• Maximum 20 mg/day regardless of response
• Do not increase beyond this limit

For patients with hepatic impairment or CYP2C19 poor metabolizers:

• Maximum 20 mg/day
• Consider baseline ECG monitoring

For patients on CYP2C19 inhibitors (cimetidine, omeprazole):

• Maximum 20 mg/day due to 68-107% increased drug exposure 1

Drug Interaction Monitoring

Citalopram has particular interaction concerns with 2:

• MAOIs: Absolutely contraindicated (14-day washout required)
• Other QT-prolonging drugs: Use extreme caution, consider ECG monitoring
• CYP2C19 inhibitors: Reduce maximum dose to 20 mg/day
• Multiple serotonergic agents: Monitor for serotonin syndrome

The combination of citalopram with other QT-prolonging psychotropic medications remains common in clinical practice despite warnings, with one study showing only modest reduction in such combinations after FDA guidance 6.